Karim S Ladha1, Elisabetta Patorno, Krista F Huybrechts, Jun Liu, James P Rathmell, Brian T Bateman. 1. From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (K.S.L., E.P., K.F.H., J.L., B.T.B.); Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (K.S.L., B.T.B.); Department of Anesthesia, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada (K.S.L.); and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (J.P.R).
Abstract
BACKGROUND: Practice guidelines for perioperative pain management recommend that multimodal analgesic therapy should be used for all postsurgical patients. However, the proportion of patients who actually receive this evidence-based approach is unknown. The objective of this study was to describe hospital-level patterns in the utilization of perioperative multimodal analgesia. METHODS: Data for the study were obtained from the Premier Research Database. Patients undergoing below-knee amputation, open lobectomy, total knee arthroplasty, and open colectomy between 2007 and 2014 were included in the analysis. Patients were considered to have multimodal therapy if they received one or more nonopioid analgesic therapies. Mixed-effects logistic regression models were used to estimate the hospital-specific frequency of multimodal therapy use while adjusting for the case mix of patients and hospital characteristics and accounting for random variation. RESULTS: The cohort consisted of 799,449 patients who underwent a procedure at 1 of 315 hospitals. The mean probability of receiving multimodal therapy was 90.4%, with 95% of the hospitals having a predicted probability between 42.6 and 99.2%. A secondary analysis examined whether patients received two or more nonopioid analgesics, which gave an average predicted probability of 54.2%, with 95% of the hospitals having a predicted probability between 9.3 and 93.2%. CONCLUSIONS: In this large nationwide sample of surgical admissions in the United States, the authors observed tremendous variation in the utilization of multimodal therapy not accounted for by patient or hospital characteristics. Efforts should be made to identify why there are variations in the use of multimodal analgesic therapy and to promote its adoption in appropriate patients.
BACKGROUND: Practice guidelines for perioperative pain management recommend that multimodal analgesic therapy should be used for all postsurgical patients. However, the proportion of patients who actually receive this evidence-based approach is unknown. The objective of this study was to describe hospital-level patterns in the utilization of perioperative multimodal analgesia. METHODS: Data for the study were obtained from the Premier Research Database. Patients undergoing below-knee amputation, open lobectomy, total knee arthroplasty, and open colectomy between 2007 and 2014 were included in the analysis. Patients were considered to have multimodal therapy if they received one or more nonopioid analgesic therapies. Mixed-effects logistic regression models were used to estimate the hospital-specific frequency of multimodal therapy use while adjusting for the case mix of patients and hospital characteristics and accounting for random variation. RESULTS: The cohort consisted of 799,449 patients who underwent a procedure at 1 of 315 hospitals. The mean probability of receiving multimodal therapy was 90.4%, with 95% of the hospitals having a predicted probability between 42.6 and 99.2%. A secondary analysis examined whether patients received two or more nonopioid analgesics, which gave an average predicted probability of 54.2%, with 95% of the hospitals having a predicted probability between 9.3 and 93.2%. CONCLUSIONS: In this large nationwide sample of surgical admissions in the United States, the authors observed tremendous variation in the utilization of multimodal therapy not accounted for by patient or hospital characteristics. Efforts should be made to identify why there are variations in the use of multimodal analgesic therapy and to promote its adoption in appropriate patients.
Authors: Michael B Rothberg; Penelope S Pekow; Maureen Lahti; Oren Brody; Daniel J Skiest; Peter K Lindenauer Journal: JAMA Date: 2010-05-26 Impact factor: 56.272
Authors: Subroto Paul; Art Sedrakyan; Ya-Lin Chiu; Abu Nasar; Jeffrey L Port; Paul C Lee; Brendon M Stiles; Nasser K Altorki Journal: Eur J Cardiothorac Surg Date: 2012-07-22 Impact factor: 4.191
Authors: Brian T Bateman; Katsiaryna Bykov; Niteesh K Choudhry; Sebastian Schneeweiss; Joshua J Gagne; Jennifer M Polinski; Jessica M Franklin; Michael Doherty; Michael A Fischer; Jeremy A Rassen Journal: BMJ Date: 2013-09-19
Authors: Michael L Kent; Robert W Hurley; Gary M Oderda; Debra B Gordon; Eric Sun; Monty Mythen; Timothy E Miller; Andrew D Shaw; Tong J Gan; Julie K M Thacker; Matthew D McEvoy Journal: Anesth Analg Date: 2019-08 Impact factor: 5.108
Authors: Sara J Hyland; Kara K Brockhaus; William R Vincent; Nicole Z Spence; Michelle M Lucki; Michael J Howkins; Robert K Cleary Journal: Healthcare (Basel) Date: 2021-03-16
Authors: Karishma Desai; Ian Carroll; Steven M Asch; Tina Seto; Kathryn M McDonald; Catherine Curtin; Tina Hernandez-Boussard Journal: J Surg Res Date: 2018-04-11 Impact factor: 2.192
Authors: Jennifer Hah; Sean C Mackey; Peter Schmidt; Rebecca McCue; Keith Humphreys; Jodie Trafton; Bradley Efron; Debra Clay; Yasamin Sharifzadeh; Gabriela Ruchelli; Stuart Goodman; James Huddleston; William J Maloney; Frederick M Dirbas; Joseph Shrager; John G Costouros; Catherine Curtin; Ian Carroll Journal: JAMA Surg Date: 2018-04-01 Impact factor: 16.681
Authors: Karim S Ladha; Brian T Bateman; Timothy T Houle; Myrthe A C De Jong; Marcos F Vidal Melo; Krista F Huybrechts; Tobias Kurth; Matthias Eikermann Journal: Anesth Analg Date: 2018-02 Impact factor: 6.627